Assenagon Asset Management’s Horizon Therapeutics Public Limited Company Ordinary Shares HZNP Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q4 | – | Sell |
-6,119
| Closed | -$708K | – | 1475 |
|
2023
Q3 | $708K | Sell |
6,119
-1,193
| -16% | -$138K | ﹤0.01% | 1098 |
|
2023
Q2 | $752K | Buy |
7,312
+64
| +0.9% | +$6.58K | ﹤0.01% | 998 |
|
2023
Q1 | $791K | Sell |
7,248
-190,475
| -96% | -$20.8M | ﹤0.01% | 1073 |
|
2022
Q4 | $22.5M | Sell |
197,723
-10,481
| -5% | -$1.19M | 0.08% | 207 |
|
2022
Q3 | $12.9M | Sell |
208,204
-55,309
| -21% | -$3.42M | 0.05% | 276 |
|
2022
Q2 | $21M | Sell |
263,513
-859,737
| -77% | -$68.6M | 0.08% | 202 |
|
2022
Q1 | $118M | Buy |
1,123,250
+1,013,364
| +922% | +$107M | 0.33% | 46 |
|
2021
Q4 | $11.8M | Sell |
109,886
-323,475
| -75% | -$34.9M | 0.03% | 263 |
|
2021
Q3 | $47.5M | Buy |
433,361
+364,321
| +528% | +$39.9M | 0.15% | 97 |
|
2021
Q2 | $6.47M | Buy |
+69,040
| New | +$6.47M | 0.02% | 397 |
|
2020
Q3 | – | Sell |
-54,899
| Closed | -$3.05M | – | 1408 |
|
2020
Q2 | $3.05M | Buy |
+54,899
| New | +$3.05M | 0.02% | 438 |
|
2020
Q1 | – | Sell |
-65,830
| Closed | -$2.38M | – | 1025 |
|
2019
Q4 | $2.38M | Buy |
+65,830
| New | +$2.38M | 0.02% | 358 |
|